AI news
Boltz announces $110 million Series A for molecular design AI
Boltz announced a $110 million Series A led by Bessemer Venture Partners to invest in compute, data and its molecular design tools. The company says six top-20 pharma companies are partners and reports growth in usage; those operating claims come from Boltz and are not proof of drug-development outcomes.
Primary source · November 18, 2026
Opens Boltz in a new tab. Read it there before you rely on the summary above.
Read the original
Free, email only
Unlock the full brief free.
- What to check before you trust this story, written down
- Each verified source, with why it matters and who published it
- A note whenever a source has been withdrawn
- Thirty days of stories to browse, not seven
Continuing subscribes the email on that account to Work Worth Doing, my newsletter, the same as the form below, and unlocks every free tool in this browser. We only receive your email address. Unsubscribe in one click.
